Sofosbuvir
索非布韦 | Sofosbuvir | 1190307-88-0 | Mumba |
SFBM | 1256490-31-9 | Mumba | |
SFB-8 | 874638-80-9 | Mumba | |
SFB-10 | 817204-32-3 | Mumba | |
SFBA-1 | 863329-66-2 | Mumba | |
SFBMA | 1334513-02-8 | Mumba |
Generic Zita: sofosbuvir (soe FOS bue vir)
Mazita eBrand: Sovaldi
Sofosbuvir mushonga unorwisa mavhairasi unoshandiswa kurapa chisingaperi hepatitis C muvakuru nevana vangangoita makore matatu uye HCV RNA replication inhibitor ine EC50 ye92 nM.
Sofosbuvir inofanira kupihwa pamwe chete nemimwe mishonga inorwisa mavhairasi (kazhinji ribavirin ine kana isina peginterferon alfa).Sofosbuvir haifanirwe kushandiswa yoga.
Sofosbuvir inobata chaiyo genotypes yehepatitis C, uye mune vamwe vanhu chete.Shandisa mishonga yawakanyorerwa chete.Usagovana mushonga wako nevamwe vanhu.
Sofosbuvir dzimwe nguva inoshandiswa muvanhu vane HIV, kana vanhu vane gomarara rechiropa uye vachazoiswa chiropa.Mushonga uyu hausi mushonga weHIV kana AIDS.
Storage
Upfu | -20°C | 3 years |
4°C | 2 years | |
In solvent | -80°C | 6 mwedzi |
-20°C | 1 mwedzi |
Chimiro chemakemikari
Proposal18Quality Consistency Evaluation mapurojekiti akatenderwa4,uye6mapurojekiti ari pasi pekubvumidzwa.
Yepamberi yepasirese yemhando manejimendi system yakaisa hwaro hwakasimba hwekutengesa.
Kutariswa kwemhando yepamusoro kunofamba kuburikidza nehupenyu hwese kutenderera kwechigadzirwa kuti ive nechokwadi chemhando nekurapa.
Professional Regulatory Affairs timu inotsigira zvinodiwa zvemhando panguva yekushandisa uye kunyoreswa.